REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 91 filers reported holding REGENXBIO INC in Q3 2017. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $140 | -100.0% | 7 | -100.0% | 0.00% | -100.0% |
| Q3 2022 | $489,000 | -96.5% | 18,500 | -96.7% | 0.00% | -96.6% |
| Q2 2022 | $14,017,000 | -18.4% | 567,500 | +9.7% | 0.06% | -13.2% |
| Q1 2022 | $17,168,000 | +170.1% | 517,267 | +216.2% | 0.07% | +134.5% |
| Q2 2021 | $6,356,000 | -79.4% | 163,608 | -81.9% | 0.03% | -79.9% |
| Q1 2021 | $30,914,000 | +411.7% | 906,300 | +580.4% | 0.14% | +396.6% |
| Q4 2020 | $6,042,000 | -10.7% | 133,200 | -27.5% | 0.03% | -34.1% |
| Q2 2020 | $6,768,000 | +9.3% | 183,756 | -41.4% | 0.04% | +25.7% |
| Q2 2017 | $6,193,000 | +1270.1% | 313,586 | +1240.1% | 0.04% | +1066.7% |
| Q1 2017 | $452,000 | – | 23,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 831,014 | $15,714,475 | 6.51% |
| MPM BioImpact LLC | 617,671 | $11,680,159 | 3.03% |
| Sonic GP LLC | 193,079 | $3,651,124 | 2.79% |
| ArchPoint Investors | 224,278 | $4,241,097 | 1.84% |
| Redmile Group, LLC | 1,640,725 | $31,026,110 | 1.35% |
| MIRABELLA FINANCIAL SERVICES LLP | 25,983 | $5,461,344 | 0.83% |
| WS MANAGEMENT LLLP | 396,997 | $7,507,213 | 0.79% |
| Redwood Wealth Management Group, LLC | 15,190 | $287,243 | 0.33% |
| SummerHaven Investment Management, LLC | 27,503 | $520,082 | 0.30% |
| Lombard Odier Asset Management (Switzerland) SA | 130,369 | $2,465,278 | 0.22% |